Airway Stent Lung Stent Market Size, Share, Industry Trends and Forecast to 2030

Airway Stent Lung Stent Market Size & CAGR in 2021

The global airway stent lung stent market is projected to showcase a CAGR of 5.2% from 2021 to 2025. In 2021, the market size was estimated to be USD 362.14 million. As a result of this growth rate, the market is expected to reach USD 489.63 million by the year 2025.

COVID-19 Impact on the Airway Stent Lung Stent Market

The COVID-19 pandemic has had a significant impact on the global airway stent lung stent market. Due to the outbreak and subsequent lockdowns, there was a disruption in the supply chain which led to a decrease in the production of stents. Additionally, the reduction in elective surgeries during the pandemic also contributed to a decline in the demand for airway stents. However, as healthcare services gradually resume and the focus shifts towards respiratory diseases, the market is expected to recover and show growth in the coming years.

Airway Stent Lung Stent Dynamics

The airway stent lung stent market is driven by factors such as the increasing prevalence of respiratory disorders, advancements in stent technology, and a rise in geriatric population. The growing awareness about minimally invasive procedures and the rise in healthcare expenditure are also contributing to the market growth. On the other hand, the market faces challenges such as complications associated with stent placement, regulatory hurdles, and the high cost of stent placement procedures.

Segments and Related Analysis

Types of Stents:

- Self-expandable stents - Balloon-expandable stents

Applications:

- Malignant airway obstruction - Benign tracheobronchial stenosis

End-users:

- Hospitals - Ambulatory surgical centers - Others

By Region Analysis

North America

The North American region dominates the airway stent lung stent market, owing to well-established healthcare infrastructure and a high prevalence of respiratory diseases in the region. The presence of key market players and technological advancements further contribute to the market growth in North America.

Europe

Europe holds a significant share in the airway stent lung stent market, driven by the increasing geriatric population and a growing focus on minimally invasive treatments in the region. The rise in healthcare expenditure and favorable reimbursement policies also boost the market growth in Europe.

Asia Pacific

The Asia Pacific region is projected to witness a high growth rate in the airway stent lung stent market due to the increasing prevalence of respiratory disorders, improving healthcare infrastructure, and rising investments in medical research and development. The presence of a large population base also creates opportunities for market growth in the Asia Pacific region.

Latin America

Latin America is expected to show steady growth in the airway stent lung stent market, supported by the rising adoption of minimally invasive procedures and increasing awareness about respiratory diseases in the region. The growing healthcare expenditure and advancements in medical technology further contribute to the market growth in Latin America.

Middle East and Africa

The Middle East and Africa region are likely to witness a gradual increase in the airway stent lung stent market, driven by the improving healthcare infrastructure and growing focus on respiratory health in the region. The increasing investments in healthcare and the rising prevalence of respiratory disorders are expected to fuel the market growth in the Middle East and Africa.

Key Market Players and Competitive Landscape

Key players in the airway stent lung stent market include Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical Incorporated, Micro-Tech (Nanjing) Co., Ltd., Novatech SA, Taewoong Medical Co., Ltd., Stening SRL, EFER Endoscopy, Hobbs Medical, Inc., and others. These players focus on strategic collaborations, mergers, acquisitions, and product launches to strengthen their market presence and gain a competitive edge in the industry.

Recent Happenings in the Airway Stent Lung Stent Market

In recent developments, Boston Scientific Corporation announced the launch of a new self-expandable metal stent for tracheobronchial stenosis treatment. Cook Medical Incorporated introduced a novel balloon-expandable stent for malignant airway obstruction. These advancements in stent technology and product launches are aimed at improving patient outcomes and expanding the market presence of key players in the airway stent lung stent market.